Upregulation of the NNP-1 (novel nuclear protein-1, D21S2056E) gene in keloid tissue determined by cDNA microarray and in situ hybridization

British Journal of Dermatology

Volumn 151, Issue 6, 2004, Pages 1143-1149

  Na, Gun Yoen ^a   Seo, S K ^a   Lee, S J ^a   Kim, D W ^a   Kim, M K ^a   Kim, J C ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

cDNA microarray; Gene; In situ hybridization; Keloid; NNP 1

Indexed keywords

ADENOSINE TRIPHOSPHATE SYNTHASE BETA; CARBONYL REDUCTASE; CARBONYL REDUCTASE 3; COLLAGEN; COLLAGEN TYPE I ALPHA1; CYSTEINE PROTEINASE INHIBITOR; GENE PRODUCT; HEAT SHOCK PROTEIN 47; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 11 RECEPTOR ALPHA; LIV 1 PROTEIN; MESSENGER RNA; NOVEL NUCLEAR PROTEIN 1; NUCLEAR PROTEIN; OXIDOREDUCTASE; PHOSPHOGLYCERATE DEHYDROGENASE; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; CASE REPORT; CHROMOSOME 21; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; ENDOTHELIUM; EPIDERMIS; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KELOID; KOREA; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RNA PROBE; SKIN EPITHELIUM; STAINING; SUPPRESSOR GENE;

ADOLESCENT; ADULT; DNA, COMPLEMENTARY; FEMALE; HUMANS; IN SITU HYBRIDIZATION; KELOID; MALE; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; UP-REGULATION;

EID: 11144284874     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06284.x     Document Type: Article

References (27)

1. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995; 33: 117-23.
2. Kelly AP. Keloids. Dermatol Clin 1988; 6: 413-24.
3. Kischer CW, Brody GS. Structure of the collagen nodule from hypertrophic scars and keloids. Scan Electron Microsc 1981; 3: 371-6.
4. Ehrlich HP, Desmouliere A, Diegelmann RF et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994; 145: 105-13.
5. Gold MH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. A dermatologic experience. J Dermatol Surg Oncol 1993; 19: 912-16.
6. Norris JE. Superficial X-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast Reconstr Surg 1995; 95: 1051-5.
7. Borgognoni L. Biological effects of silicone gel sheeting. Wound Repair Regen 2002; 10: 118-21.
8. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol 2002; 47: S209-11.
9. Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol 1998; 8: 591-5.
10. Alhady SM, Sivanantharajah K. Keloids in various races. A review of 175 cases. Plast Reconstr Surg 1969; 44: 564-6.
11. Muir IF. On the nature of keloid and hypertrophic scars. Br J Plast Surg 1990; 43: 61-9.
12. Laurentaci G, Dioguardi D. HLA antigens in keloids and hypertrophic scars. Arch Dermatol 1977; 113: 1726.
13. Rossi A, Bozzi M. HLA and keloids: antigenic frequency and therapeutic response. G Ital Dermatol Venereol 1989; 124: 341-4.
14. Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 1974: 53: 276-80.
15. Marneros AG, Norris JE. Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001; 137: 1429-34.
16. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003; 111: 535-46.
17. Bayat A, Bock O, Mrowietz U et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002; 55: 283-6.
18. Chen W, Fu X, Sun X et al. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res 2003; 113: 208-16.
19. Luo L, Salungs RC, Guo H et al. Gene expression profiles of laser-captured adjacent neuronal subtype. Nat Med 1999; 5: 117-22.
20. Grunewald-Janos S, Keesey J, Leous M et al. Nonradioactive in situ Hybridization Application Manual, 2nd edn. Mannheim: Roche Diagnostics, Boehringer Mannheim, 1996.
21. Kauh YC, Rouda S, Mondragon G et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997; 37: 586-9.
22. Naitoh M, Hosokawa N, Kubota H et al. Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid. Biochem Biophys Res Commun 2001; 280: 1316-22.
23. Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000; 89: 74-7.
24. Oriente A, Fedarko NS, Pacocha SE et al. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000; 292: 988-94.
25. Jansen E, Meulemans SMP, Orlans ICR, van de Ven WJM. The NNP-1 gene (D21S2056E), which encodes a novel nuclear protein, maps in close proximity to the cystatin B gene within the EPM1 and APECED critical region on 21q22.3. Genomics 1997; 42: 336-41.
26. Savino TM, Bastos R, Jansen E, Hernandez-Verdun D. The nucleolar antigen Nop52, the human homologue of the yeast ribosomal RNA processing RRP1, is recruited at late stages of nucleologenesis. J Cell Sci 1999; 112: 1889-900.
27. Teofoli P, Barduagni S, Ribuffo M et al. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci 1999; 22: 31-7.